Monsanto Company (MON) is Upgraded by Monness Crespi & Hardt to Buy, Price Target at $130

Monsanto Company (MON) was Upgraded by Monness Crespi & Hardt to ” Buy” and the brokerage firm has set the Price Target at $130. Earlier the firm had a rating of “Neutral ” on the company shares. Monness Crespi & Hardt advised their investors in a research report released on Aug 8, 2016.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Monsanto Company opened for trading at $106.48 and hit $107.48 on the upside on Friday, eventually ending the session at $106.93, with a gain of 0.48% or 0.51 points. The heightened volatility saw the trading volume jump to 21,95,770 shares. Company has a market cap of $46,790 M.

In a different news, on Jul 15, 2016, Michael K Stern (VP, CEO – Climate) sold 12,797 shares at $101.77 per share price. According to the SEC, on Jul 15, 2016, Brett D Begemann (President & COO) sold 27,980 shares at $103.62 per share price. On Apr 21, 2016, George Poste (director) sold 1,136 shares at $91.93 per share price, according to the Form-4 filing with the securities and exchange commission.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Monsanto Company

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.